This protocol describes the surgical technique for harvesting a human perforator flap model based on the deep inferior epigastric artery pedicle, intended for experimental research.
Method Article
This protocol describes the surgical technique for harvesting a human perforator flap model based on the deep inferior epigastric artery pedicle, intended for experimental research.
Recently, preservation approaches such as cytoprotective agents injection, ex vivo machine perfusion, and supercooling have emerged as strategies to enhance long-term preservation of both standard and marginal organs by mitigating ischemic and hypoxic injury. Although encouraging, its application in the field of vascularized composite allotransplantation (VCA) remains largely confined to preclinical research. To date, most studies investigating VCA perfusion strategies have relied on animal models, particularly swine or rodent composites. While these models provide valuable mechanistic insights, their anatomical, immunological, and physiological differences limit reproducibility and translational relevance to human applications.
In this protocol, each surgical step required for the procurement of a human deep inferior epigastric perforator (DIEP) flap for preservation studies is described in detail. The perforator is transected above the fascia without any subfascial dissection, yielding a short yet sufficient pedicle for catheterization. This model takes advantage of discarded tissue from standard abdominoplasty procedures, posing no additional risk to the patient. Critical steps are outlined to ensure a functional flap is harvested without prolonging operative time or compromising patient safety. Functional imaging is subsequently performed to confirm flap viability prior to experimental use, and sequential biopsies may be performed to follow tissue integrity. This model is particularly suited for research involving muscle-sparing VCA procedures -- such as partial facial transplantation -- and may also have relevance for the study of autologous free flap preservation.
Vascularized composite allotransplantation (VCA) represents a promising reconstructive solution for patients with complex tissue defect, particularly in the face and upper limbs1. However, VCA is highly susceptible to ischemia-reperfusion injury, which can compromise graft viability and long-term outcomes2. In this context, preservation approaches such as cytoprotective agents injection, ex vivo machine perfusion, and supercooling have emerged as strategies to extend preservation time, optimize graft quality, and enable viability assessment prior to transplantation3,4,5,6,7. While normothermic ex vivo perfusion of solid organs has been successfully translated from an experimental laboratory technique into clinical practice over the past decade8, with promising results, it remains largely confined to the research setting in the field of VCA9.
To date, most studies investigating VCA perfusion protocols have relied on animal models, particularly swine or rodent composites10. While these models offer valuable insights, they inherently limit reproducibility and translational relevance due to anatomical, immunological, and physiological differences11,12. Human tissue models provide more relevant insights, but fresh tissues from brain-dead donors are extremely difficult to access for research purposes, requiring complex logistics, strict regulatory approval, and raising ethical concerns13,14. An ideal alternative would be a non-cadaveric, ethically acceptable, human-based flap model that does not carry the complexity or risk of a full VCA procedure and is entirely safe for the patient. Importantly, it should also be easily accessible to facilitate reproducible, scalable research.
Herein, a human deep inferior epigastric perforator (DIEP) flap model for VCA preservation research is described, using discarded tissue from abdominoplasty procedures without any additional risk to the patient.
All patients received standard humane care in accordance with the Helsinki Declaration, and the protocol was approved by the institutional ethics committee (project No. IRB00014528_2025_32). The patient provided informed consent for the use of discarded tissue for research purposes.
1. Preoperative care
NOTE: These cutaneous perforator flaps, excluding fascia and muscle, are derived from surgical waste in patients, most often post-bariatric, and can only be harvested in cases of prior dermolipectomy with predictable umbilical transposition (i.e., a significant abdominal pannus). Planned liposuction during the procedure is an exclusion criterion. Concomitant diastasis repair is not a contraindication, as this procedure occurs after flap harvesting. The abdominal pannus generally provides at least partial coverage of the pubic area. Patients must have no history of thromboembolic events, and the body mass index (BMI) must be below 30 kg/m², as higher values are associated with obesity and an unfavorable risk-benefit ratio for elective non-vital procedures under general anesthesia. Previous abdominal surgery, except liposuction, is usually not a contraindication, provided that a perforator is identified by Doppler examination or directly visualized intraoperatively. This research procedure should also be avoided in true clinical unilateral DIEP free-flap reconstructions, which are already lengthy and complex operations where additional preoperative steps would be irrational and increase procedural risk.

Figure 1: Preoperative evaluation before post-bariatric abdominal dermolipectomy with DIEP flap harvest. (A) Preoperative marking performed using an acoustic Doppler and a dermographic pen to identify and outline the paraumbilical perforators on each side of the midline. (B) The surgeon demonstrates the laxity of the abdominal skin and subcutaneous tissue to be resected, highlighting the adipocutaneous panniculus before incision along the horizontal marking line. Please click here to view a larger version of this figure.
2. Flap procurement

Figure 2: Intraoperative view of the abdominal dermolipectomy procedure with skeletonization of the deep inferior epigastric perforator pedicles. The image shows the operative field before supraumbilical dissection and longitudinal infraumbilical division. The two dominant bilateral paraumbilical deep inferior epigastric perforators are exposed and highlighted with surgical instruments. Please click here to view a larger version of this figure.

Figure 3: Intraoperative view after supraumbilical dissection showing the bilateral deep inferior epigastric perforators. The perforators are not ligated, and their subfascial course and length can be better appreciated under gentle traction (white arrows). Please click here to view a larger version of this figure.

Figure 4: Intraoperative view showing the DIEP flaps outlined on the skin in an elliptical shape before ligation. (A) The skin paddle is adjusted and outlined in an elliptical shape using a dermographic pen (white circle) to ensure inclusion of the perforator along the medial edge of the flap on each side of the adipocutaneous panniculus. (B) Enlarged view showing the DIEP flap outline and the perforator marked with an "x" according to preoperative Doppler mapping (white arrow). Please click here to view a larger version of this figure.
Supplementary Figure 1: Downward traction on the upper abdominal flap helps determine the amount of redundant skin to be resected. The long end of the midline non-absorbable suture connecting the supraumbilical and pubic regions is used as a guide. Using a dermographic pen, draw the resection line along the course of the suture (white arrows) on the redundant adipocutaneous panniculus. Extend this line laterally toward each anterior superior iliac spine. The DIEP flaps are located below this marked resection line. Please click here to download this File.

Figure 5: Intraoperative view of the deep inferior epigastric artery perforator (DIEP) flaps during harvest, following pedicle ligation. (A) The DIEP flap, measuring approximately 10 cm × 6 cm, is outlined with a surgical marker after localization of the perforator. (B) Skin incision and flap harvest are performed along the pre-established markings. The initial incision is made with a No. 15 blade, followed by dissection using a monopolar electrocautery set at approximately 50-60 °C, and 80 W in coagulation mode, when the excess cutaneous-adipose tissue remains attached to the patient. When the tissue has been completely detached, a sterile, single-use, battery-operated disposable cautery pen (large tip, approximately 1,200 °C) is used to complete the separation. Please click here to view a larger version of this figure.
3. Preparation of the flap

Figure 6: Post-harvest view of a research DIEP flap. (A) The harvested DIEP flap is shown with the vascular pedicle dissected and isolated using microsurgical forceps. The arterial end is trimmed by a few millimeters to obtain a clean cut, and the lumen is gently opened with a micro-dilator forceps. (B) Close-up view showing microsurgical forceps securing the dominant perforator artery, with a 24-G catheter inserted into the lumen for contrast agent injection. Please click here to view a larger version of this figure.

Figure 7: Catheterization of the DIEP flap pedicle. (A) The catheter is secured in place with a 5-0 silk suture tied gently to avoid obstructing the lumen of the pedicle. (B) View of the catheter positioned without the syringe attached, showing the extent of catheter insertion into the vascular lumen. Please click here to view a larger version of this figure.

Figure 8: Post-harvest fluoroscopy of the DIEP flap demonstrating the vascular anatomy. (A,B) Contrast agent is injected through a 24-G catheter into the dominant perforator artery, depicting the branching pattern and the vascularized area, confirming flap viability on two different flaps. Please click here to view a larger version of this figure.
Eleven flaps were harvested from six female patients included in this study. Two senior plastic surgeons, experienced in flap surgery and abdominoplasty, performed the dissections. In one patient, the flap was harvested unilaterally due to a dissection issue. The harvested flaps had a mean weight of 198.6 ± 24.4 g (n = 11) and an average size of 10 cm × 6 cm, which corresponded to the sample requirements for the preservation study in which these flaps were used. The pedicle length, measured under gentle tension, averaged 3.85 ± 0.74 cm, and the external vessel diameter, measured with a caliper, was 1.2 ± 0.3 mm. The catheter was observed to be inserted to an average depth of 1.75 cm (n = 2). All flaps demonstrated good perfusion on arteriography, with homogeneous and complete vascular filling throughout the flap, as assessed similarly in previous studies15.
The total mean operative time for standard abdominoplasty with umbilical transposition in a case series of six patients was 123 ± 24 min. There was no significant difference in operative time among these six procedures (p = 0.61). To assess any difference compared with the standard procedure without research flap harvest, the records of six patients who underwent similar surgery at the University Hospital were retrospectively reviewed (abdominoplasty with abdominal transposition). The mean operative time was 131 ± 21 min. There was no statistically significant difference in operative time compared with the six standard abdominoplasty procedures without flap harvest (p = 0.47, two-tailed Student's t-test).
No postoperative abdominal wall deficits or infections were observed in any of the six patients included in the study, with a mean follow-up of 6.5 ± 5.8 months (minimum: 2 weeks; maximum: 14 months) (Table 1).
In this protocol, the flaps were used for cytoprotective agent injection studies, and catheterization via the arterial pedicle was performed using either a 22- or 24-G catheter without technical difficulty, as in this protocol. Venous catheterization is not required in this type of study, consistent with static cold storage and supercooling protocols. The outcome of the catheterized flap depends on the protocol used. In this study, eleven DIEP flaps were included in a protocol designed to evaluate the effect of a cytoprotective agent, an inhibitor of eIF5A hypusination. After catheterization, the flaps were wrapped in sterile surgical towels, placed in sterile vacuum-sealed bags, and labeled. In the experience we conducted on these flaps, two experimental groups were defined: a control group perfused with University of Wisconsin preservation solution, and a treatment group receiving the cytoprotective agent administered intra-arterially through the vascular pedicle. All flaps were stored under static cold conditions at 4 °C in sealed bags immersed in ice water within an insulated container. Two 0.8-mm punch biopsies were taken from identical locations on both treated and control flaps at predefined time points: baseline (t = 0, before preservation), and after 1, 2, 4, 6, 8, 12, 24, 36, and 48 hours of cold ischemia. Tissue samples were fixed overnight in 10% neutral buffered formalin and embedded in paraffin. Four-micrometer sections were then deparaffinized in xylene, rehydrated through graded alcohols, and washed in phosphate-buffered saline (PBS). Sections were stained with hematoxylin and eosin for microscopic analysis. Histological evaluation was performed in a blinded fashion to compare treated and control flaps and to assess time-dependent ischemic changes over a 48-h period (Figure 9).

Figure 9: Representative hematoxylin and eosin (HE) image. Representative histology of flap biopsy cross-sections stained with HE from 0-48 h after surgical resection, following treatment with a single cytoprotective agent at the time of harvest. Scale bar = 100 µm. Please click here to view a larger version of this figure.
| Parameter | n | Mean ± SD | Range (Min–Max) | Unit | Notes |
| Flap weight | 11 | 198.6 ± 24.4 | 148–218 | g | Average flap size 10 × 6 cm |
| Pedicle length | 11 | 3.85 ± 0.74 | 2.1–4.6 | cm | Measured under gentle tension |
| External vessel diameter | 11 | 1.2 ± 0.3 | 0.9–1.5 | mm | Measured with caliper |
| Catheter insertion depth | 2 | 1.75 ± 0.21 | 1.6–1.9 | cm | Average depth for 24-G catheter |
| Operative time | 11 | 123 ± 24 | 98–165 | min | No significant difference (p = 0.61) |
| Post-operative follow-up | 11 | 6.5 ± 5.8 | 0.5–14 | months | No wall deficit or infection observed |
Table 1: Main characteristics of the harvested DIEP research flaps. Summary of morphometric and operative parameters from eleven research DIEP flaps harvested during abdominoplasty procedures. Measurements include flap weight, pedicle length, external vessel diameter, and catheter insertion depth. Operative time and postoperative follow-up were recorded to assess surgical safety and reproducibility. No postoperative abdominal wall complications or infections were observed.
Human models help bridge findings from animal studies to clinical practice, improving the relevance and predictivity of preclinical research16,17,18. They must be carefully designed to ensure safety and ethical compliance, often limiting the scope and invasiveness of experiments17. Across the four harvested flaps, no additional dissection was necessary, and there was no significant prolongation of operative time in any of the cases. The relatively large diameter of the vessels of this flap (1.2 mm mean) makes cannulation easy in comparison with animal models. Clinical observation of flap perfusion is also relatively easier through the abdominal skin. Unlike the flaps commonly used in clinical practice (DIEP and transverse rectus abdominis myocutaneous [TRAM]), this experimental model does not involve any incision of the rectus abdominis fascia or muscle harvesting. Consequently, although the described flap pedicle is shorter, its length remains adequate for experimental preservation studies (Figure 10).
Regarding the final step and flap cannulation, it depends on the preservation studies. For cytoprotective agent injection studies, catheterization via the arterial pedicle can be performed using either a 22- or 24-G catheter without technical difficulty, as in this protocol. For ex vivo machine perfusion studies, a systematic literature review highlights that, in large animal studies using grafts of comparable size to the one presented here, arterial catheterization is typically performed with 18-20 G catheters and venous catheterization with 16-18 G catheters5. The specific perfusion system and catheter size depend on the animal species and the graft type. For ECMO studies, Ozturk et al. developed a human extracorporeal free flap perfusion model using a pediatric ECMO device to perfuse a DIEP flap comparable to the one described in this study. Their setup included a centrifugal pump head connected to a pediatric hollow-fiber oxygenator with a countercurrent heat exchanger and a 150-mL cardiotomy reservoir with a filter, all integrated into a standard pediatric ECMO circuit. The tubing diameter was adjusted to the appropriate range (16-20 G), confirming that the catheters are insertable into such flaps, which typically range from 16 to 20 G19.

Figure 10: Schematic representation of the harvested deep inferior epigastric artery perforator (DIEP) flap for research versus clinical purposes, illustrating differences in harvest technique according to the intended use of the flap. (A) Research DIEP (preservation study): the flap is harvested without muscle or fascia, and the pedicle dissection remains suprafascial to avoid harming the patient. (B) Clinical DIEP (free flap reconstruction): the flap is also harvested without muscle or fascia, but a subfascial dissection is performed to obtain additional pedicle length for subsequent microsurgical anastomosis. Please click here to view a larger version of this figure.
To date, this model has rarely been described19,20. The most relevant report briefly outlined the use of a deep inferior epigastric artery perforator flap model for extracorporeal perfusion with an extracorporeal membrane oxygenation device, achieving a mean perfusion duration of 6 days. Yet, it requires careful preparation and an optimized strategy to ensure both patient safety and model integrity. In their description, Ozturk et al. folded the flap onto itself after excision, shaped it into a tube, and sutured it, a method that may compromise anatomical fidelity and perfusion assessment19. Since the deep inferior epigastric arteries are bilateral, harvesting two smaller flaps of the same size can be preferred, with a contralateral flap that can be used as a reliable control from the same abdominoplasty specimen and during the same procedure.
The use of arteriography or intra-arterial fluorescein in a research setting can be useful to ensure the validity of the model and confirm homogeneous perfusion throughout the entire flap. Indeed, evaluating flap preservation often relies on biopsies, and if these are taken from poorly perfused areas, the results may be misleading. Arteriography can also assist in guiding the resection, helping to optimize the harvesting procedure.
There is currently no consensus on the optimal temperature for ex vivo machine perfusion (EVMP), for either solid organ transplant21 or VCA9. This model is particularly relevant for subnormothermic and normothermic perfusion studies, where maintaining an optimal balance between metabolic demand and preservation time is critical. Conversely, hypothermic perfusion is of limited relevance for muscle-free VCAs and cutaneous flaps, as their inherently low metabolic activity reduces the benefits of such cooling strategies22. To a lesser extent, it can also support decellularization and recellularization research, as it provides fresher tissue than any cadaveric source could offer23,24. Moreover, the proposed model is relatively simple to perform for a plastic surgeon, whereas VCA models based on cadaveric or brain-dead donors are technically demanding and require extensive specialized training25,26,27,28.
Doppler ultrasound is recommended, as it is non-irradiating, inexpensive, and provides rapid localization of perforators for an experienced operator29. However, its use is not mandatory, since under direct vision, the perforator is usually located within a few centimeters of the umbilicus, as consistently reported in multiple anatomical studies on DIEP flaps29. Preoperative CT angiography is not justified in the setting of abdominoplasty-derived research flaps, as it is both irradiating and costly. In this study, fluoroscopic assessment was performed for all 11 harvested flaps prior to cytoprotective treatment, consistently demonstrating homogeneous vascular opacification without evidence of misinterpretation or tissue injury. For small flaps of approximately 10 cm × 6 cm, omitting fluoroscopy can reasonably save time before initiating the preservation protocol, provided the procedure is performed by an experienced surgeon or when fluoroscopy is not readily available. Perfusion assessment relies primarily on the surgeon's experience, with homogeneous vessel opacification confirming adequate flap perfusion. For larger flaps, fluoroscopy remains recommended to ensure complete vascular integrity. Although not performed in the present study, indocyanine-green angiography may also be used for perfusion assessment; however, it does not provide a significant time advantage compared with fluoroscopy.
While the procedure is technically straightforward, it presents several practical limitations that require anticipation and close coordination between the surgical and research teams. If the operating surgeon is not comfortable harvesting the flap while it remains attached to the patient, preferring instead the conventional abdominoplasty approach based on bilateral panniculus excess measurements, the excision can be performed in the usual manner, and the discarded tissue subsequently transferred to the research team. This workflow requires close collaboration between the surgical and research teams. The research team must be prepared to handle the flap immediately after excision to prevent prolonged ischemia, with all experimental materials and instruments ready in advance. The operating surgeon should have prior experience in abdominal wall surgery, typically in digestive or plastic surgery, and be familiar with the basic principles of flap physiology, particularly hemodynamics. Similarly, the research team should be trained in primary manipulation of microsurgical instruments to ensure proper handling of the specimen; even minor trauma from sharp microforceps can damage the pedicle or compromise perfusion30. The use of monopolar electrocautery carries a risk of thermal injury, particularly when operating near the perforator pedicle. To minimize this risk, coagulation should be performed at moderate power, with continuous saline irrigation to prevent heat accumulation, and scissors should be used for dissection when working in close proximity to the pedicle. Proper placement of the return electrode is essential to avoid skin burns, as in any surgical procedure31. Fluoroscopy for contrast injection must follow radiation safety standards, including the use of lead aprons and minimizing exposure through low-dose settings and beam collimation. In our series, one case of intraoperative perforator identification failure occurred (no suitable perforator was found on one side of the umbilicus, and the others were accidentally transected). No cannulation leaks were observed with the 22-24-G injection protocol, and incomplete opacification on fluoroscopy was not encountered. The model itself also presents significant drawbacks. Unlike most VCAs, it does not include bone or muscle components but consists solely of vascularized soft tissue. As such, it does not allow for the study of muscle viability or the early ischemic damage typically observed in muscle compartments during VCA. Nevertheless, it is worth noting that many partial face transplants have been performed without muscle32,33,34, particularly when the defect involves only the skin, subcutaneous tissue, and occasionally portions of facial bone or mucosa. Additionally, although anatomically realistic, this model does not reproduce the systemic physiological and inflammatory milieu associated with brain-dead organ donors, which may influence immune activation and endothelial injury in VCA settings25,35. The relatively short pedicle length, while sufficient for perfusion and injection studies, may limit compatibility with certain ex vivo perfusion devices compared with larger animal models. Inter-donor variability in flap thickness, vascular anatomy, and perfusion pattern also represents an inherent limitation, potentially affecting reproducibility in experimental applications. This can be mitigated by using pairwise contralateral control flaps when available and by standardizing perfusion solutions, flow rates, and environmental conditions. Finally, the representative data presented here are based on relatively small flaps (10 cm × 6 cm) and have not been tested for reproducibility in larger specimens. Further validation would be required to confirm whether fluoroscopy or other perfusion assessment methods can be safely omitted in larger flap models.
This model may also be beneficial for research on autologous flap preservation36. While the preservation of autologous tissue is generally considered less critical, it can become relevant in specific situations, such as saving time for free flap rescue or complex logistical scenarios37,38,39.
The authors have nothing to disclose.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 1 mL and 5 mL Luer-Lok syringe | Becton Dickinson | https://www.bd.com/en-us/products-and-solutions/products/product-page.309646 | |
| 11.5” Medium and Small Premium Surgiclip II Auto Suture vessel clip applier | Covidien | N/A | |
| 22–24 G vessel cannula blunt tip | Medtronic Inc | N/A | |
| 5-0 silk suture | N/A | Any compatible suture | |
| A single-use, battery-powered disposable cautery pen | Helpmedical, Europe | N/A | 1200 °C, large-tip |
| Adson Forceps | MPM | 106-2112A | |
| Bipolar Coagulation Forceps | Olsen | 20-1320I | |
| Disposable Scalpel #15 & #21 | Sklar | N/A | |
| Eosin | Microm Microtech | U/C0363 | |
| Faraboeuf retractors | Medicta Instruments | N/A | |
| Fine needle cautery | Cormedica | N/A | |
| OEC MiniView Max | GE Healthcare | N/A | Fluoroscopy system |
| Forceps Dilators | WPI | 15910 | |
| Hematoxylin | Microm Microtech | U/C0303 | |
| Iohexol 300 mg I/mL | GE Healthcare Canada Inc. | N/A | |
| Micro scissors | WPI | 504492 | |
| Valleylab Monopolar Diathermy | Medtronic Inc | ||
| Non-ionic iodinated contrast medium, Omnipaque 300 mg I/mL | GE Healthcare | N/A | |
| Portable acoustic Doppler, 8 MHz | Parks Medical Electronics | https://www.parksmed.com/ | |
| Saline solution 0.9% | GenDepot | S0600-101 | |
| Standard plastic surgery instrument set | Aesculap | N/A | including scalpel handle No. 3, Metzenbaum and Mayo scissors, Adson and Gillies forceps, dissecting scissors, hemostats, and needle holders. |
| Strabismus scissors | Surtex | 102-4109 | |
| Surgical marking pen | Cardinal health | 212PR | |
| Sutures Ethilon 4.0 and 3.0 | Ethicon | 1667G | |
| Tissue Forceps | MPM | 106-0511 |